$STI

Solidion Technology Inc.

CIK:0001881551|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 124,914	$ 4,000	$ 210,340	$ 4,000
Cost of goods sold		2,327	1,696	2,327
Gross profit	124,914	1,673	208,644	1,673
Operating Expenses
Research and development	370,802	399,542	773,189	1,752,592
Selling, general and administrative	1,121,449	1,389,255	2,577,085	3,168,874
Total operating expenses	1,492,251	1,788,797	3,350,274	4,921,466
Operating loss	(1,367,337)	(1,787,124)	(3,141,630)	(4,919,793)
Other Income (Expense)
Change in fair value of derivative liabilities	(917,780)	(216,150)	(356,430)	12,201,300
Interest income	35,130	1,886	35,321	18,157
Interest expense	(153,597)	(112,471)	(300,830)	(218,893)
Other (expense)	(483,172)		(553,855)
Total other income (expense)	(1,519,419)	(326,735)	(1,175,794)	12,000,564
Net income (loss) before provision for income taxes	(2,886,756)	(2,113,859)	(4,317,424)	7,080,771
Provision for income taxes
Net Income (loss)	$ (2,886,756)	$ (2,113,859)	$ (4,317,424)	$ 7,080,771
Weighted average number of shares of common stock outstanding, basic (in Shares)	8,357,332	3,002,802	8,074,545	3,002,295
Basic net income (loss) per share of common stock (in Dollars per share)	$ (0.35)	$ (0.7)	$ (0.53)	$ 2.36
Weighted average number of shares of common stock outstanding, diluted (in Shares)	8,357,332	3,002,802	8,074,545	3,377,247
Diluted net loss per share of common stock	$ (0.35)	$ (0.7)	$ (0.53)	$ (0.53)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows From Operating Activities:
Net income (loss)	$ (4,317,424)	$ 7,080,771
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	134,800	138,400
Stock based compensation	571,069	957,869
Equity compensation expense		671
Non-cash interest expense		202,920
Amortization of debt discount	62,562
Accrued interest on short-term note payable - related party	1,775
Change in fair value of derivative liabilities	356,430	(12,201,300)
Changes in operating assets and liabilities:
Accounts receivable	(41,994)	(4,112)
Prepaid expenses	47,058	(139,453)
Other current assets	(192,800)	(431,608)
Accounts payable and accrued expenses	(847,995)	1,118,918
Income taxes payable		(6,369)
Excise taxes	124,052	27,296
Due to related party	(12,873)
Net Cash Used In Operating Activities	(4,115,341)	(3,255,997)
Cash Flows From Investing Activities:
Purchases of property and equipment		(117,812)
Capitalized patent costs	(45,432)	(63,686)
Net Cash Used In Investing Activities	(45,432)	(181,498)
Cash Flows From Financing Activities:
Proceeds from issuance of common stock and warrants in connection with the Private Placement	34,994,842
Offering costs for common stock and warrants issuance in connection with the Private Placement	(2,814,747)
Proceeds from issuance of common stock from exercise of warrants		241,546
Proceeds from short-term notes payable	75,000
Proceeds from short-term notes payable – related party	75,000
Repayment of short-term notes payable	(696,732)	(42,671)
Cash used to settle fractional shares		(460)
Net Cash Provided By Financing Activities	31,633,363	198,415
Net change in cash	27,472,590	(3,239,080)
Cash at beginning of period	204,725	3,353,732
Cash at end of period	27,677,315	114,652
Supplemental disclosure
Cash paid for interest expense	95,781	7,329
Cash paid for federal income taxes		6,369
Supplemental disclosure of non-cash financing activities:
Issuance of Common Stock upon the closing of the Merger		414
Issuance of stock purchase warrants	1,938,014
Issuance of Common Stock upon cashless exercise of warrants	2
Forward Purchase Agreement discount accretion	159,618
Debt discount recognized on note payable	85,000
Issuance of promissory note in settlement of due to related party	75,000
Convertible notes converted to common shares		527,500
Reclassification of warrant derivative liability to additional paid-in capital upon exercise of Series A warrants	357,139
Capitalized interest to principal balance of short-term note payable		202,920
Reverse stock split — reclassification from common stock to additional paid-in capital		13,311
Shares issued upon settlement of warrants	$ 24

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 27,677,315	$ 204,725
Accounts receivable	47,105	5,110
Other receivable	302,500	302,500
Inventory	24,430	24,430
Prepaid expenses	123,199	170,257
Other current assets	268,966	76,166
Total Current Assets	28,443,515	783,188
Property and Equipment, net of depreciation	1,926,891	2,022,043
Patents, net of amortization	1,997,407	1,991,623
Total Assets	32,367,813	4,796,854
Current Liabilities:
Accounts payable and accrued expenses	2,676,939	3,509,936
Excise tax payable	1,088,515	964,463
Derivative liabilities	4,771,891	4,772,600
Short-term notes payable	2,003,386	2,647,556
Total Liabilities	10,692,506	11,982,428
Commitments and contingencies (Note 6)
Stockholders’ Equity (Deficit):
Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value, 300,000,000 shares authorized, 8,512,771 and 7,465,283 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	851	746
Additional paid-in capital	192,365,464	159,027,646
Stock subscription receivable	(3,001,045)	(2,841,427)
Accumulated deficit	(167,689,963)	(163,372,539)
Total Stockholders’ Equity (Deficit)	21,675,307	(7,185,574)
Total Liabilities and Stockholders’ Equity (Deficit)	32,367,813	4,796,854
Related Party
Current Liabilities:
Due to related party		87,873
Short-term notes payable – related party	$ 151,775